Research Paper Volume 16, Issue 3 pp 2410—2437
A novel PANoptosis-related long non-coding RNA index to predict prognosis, immune microenvironment and personalised treatment in hepatocellular carcinoma
Figure 5. Assessment of the PANRI in hepatocellular carcinoma. (A, B) Risk forest plots for multivariate and univariate Cox regression. (C) ROC curves of the 1-, 3- and 5-year survival in the TCGA cohort. (D–F) Comparison of risk score ROC curves with clinicopathological parameter ROC curves. (G) Tumour stage and risk status were used to construct a nomogram for predicting patient survival. (H) Calibration curves for the nomogram. *p < 0.05, **p < 0.01 and ***p < 0.001.